AMP German Cannabis Group Announces Trade Financing for the Import of EU-GMP Medical Cannabis into Germany

BERLIN, Germany, April 3rd, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) is pleased to announce that it has successfully increased the loan amount…

Continue ReadingAMP German Cannabis Group Announces Trade Financing for the Import of EU-GMP Medical Cannabis into Germany

AMP German Cannabis Group Receives Import Licence for Medical Cannabis for Imports from European Union Countries

BERLIN, Germany, March 9, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) announces that the Thuringian State Office for Consumer Protection…

Continue ReadingAMP German Cannabis Group Receives Import Licence for Medical Cannabis for Imports from European Union Countries

AMP German Cannabis Group Closes First Tranche of Non-Brokered Private Placement

 BERLIN, Germany, March 6th, 2020 – AMP German Cannabis Group Inc. (“AMP”) (CSE: XCX), (Frankfurt: C4T, ISIN: CA00176G1028) announces it has closed the first tranche of its non-brokered private placement…

Continue ReadingAMP German Cannabis Group Closes First Tranche of Non-Brokered Private Placement

AMP German Cannabis Group Announces Non-Brokered Placement Private Placement to Fund German Medical Cannabis Import Business

BERLIN, Germany, January 8, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) announces a non-brokered placement of up to 8,000,000 common…

Continue ReadingAMP German Cannabis Group Announces Non-Brokered Placement Private Placement to Fund German Medical Cannabis Import Business